Comparison of Serum proBNP and Apelin Levels in Hypertensive Crisis Versus Controlled Hypertension: Impact of Opium Addiction Status

Document Type : Original Article

Authors

1 Cardiovascular Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences, Kerman, Iran

2 Student Research Committee, Kerman University of Medical Sciences, Kerman, Iran

3 HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran

4 Physiology Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran

10.34172/ahj.1581

Abstract

Background: Hypertension (HTN) is associated with the risk of cardiovascular diseases (CVDs) and mortality. It is estimated that by 2025, 1.6 billion people worldwide will suffer from HTN. HTN crisis is characterized by severe HTN exceeding 180/120 mmHg, leading to acute myocardial infarction (AMI), acute left ventricular failure, and intracerebral hemorrhage. Apelin and N-terminal proBNP (NT-proBNP) play a role in cardiovascular homeostasis. Opium addiction has been reported to increase the risk of CVD. In this study, we compared the serum apelin and NT-proBNP levels in HTN crisis and controlled HTN, considering the impact of addiction status among patients referred to Kerman hospitals from 2018 to 2019.
Methods: Eighty-nine patients with HTN crisis and 111 controlled HTN subjects as the control group were enrolled. Each group was further divided into two subgroups: non-addicts and opium addicts. Demographic data were recorded, and serum apelin and NT-proBNP levels were measured using the ELISA method.
Findings: Our results indicated that patients with HTN crisis had higher apelin levels than controlled HTN individuals (β = 2.08, P < 0.001). Among the patients with controlled HTN, diastolic blood pressure (DBP) was higher in opium-addicted subjects compared to their non-addicted counterparts (P = 0.035). NT-proBNP levels were higher in opium-addicted patients with HTN crisis but higher in non-addicted patients with controlled HTN. Furthermore, mean age, SBP, DBP, HR, CR, and apelin were higher in patients with HTN crisis than those with controlled HTN, which was also statistically significant (P < 0.05). However, regarding NT-proBNP levels, there was no significant difference between the two groups (P = 0.175).
Conclusion: Contrary to the general belief that opium addiction has cardioprotective effects, we found that opium addiction in controlled HTN subjects was associated with higher DBP and proBNP levels were elevated in addicts with HTN crisis, indicating potential cardiac damage.

Keywords

References

  1. Pinna G, Pascale C, Fornengo P, Arras S, Piras C, Panzarasa P, et al. Hospital admissions for hypertensive crisis in the emergency departments: a large multicenter Italian study. PLoS One. 2014;9(4):e93542. doi: 10.1371/journal.pone.0093542.
  2. Baumann BM, Pescatore RM. Hypertensive emergencies. In: Brown DL, ed. Cardiac Intensive Care. 3rd ed. Philadelphia: Elsevier; 2019. p. 275-91.e5.
  3. Sekerci R, Acar N, Tepekoy F, Ustunel I, Keles-Celik N. Apelin/APJ expression in the heart and kidneys of hypertensive rats. Acta Histochem. 2018;120(3):196-204. doi: 10.1016/j. acthis.2018.01.007.
  4. Wysocka MB, Pietraszek-Gremplewicz K, Nowak D. The role of apelin in cardiovascular diseases, obesity and cancer. Front Physiol. 2018;9:557. doi: 10.3389/fphys.2018.00557.
  5. Elliott WJ. Hypertensive emergencies and urgencies. In: Bakris GL, Sorrentino MJ, eds. Hypertension: A Companion to Braunwald’s Heart Disease. 3rd ed. Elsevier; 2018. p. 427-32.
  6. Makó K, Ureche C, Jeremiás Z. An updated review of hypertensive emergencies and urgencies. J Cardiovasc Emerg. 2018;4(2):73-83. doi: 10.2478/jce-2018-0013.
  7. Ma J, Li Y, Yang X, Liu K, Zhang X, Zuo X, et al. Signaling pathways in vascular function and hypertension: molecular mechanisms and therapeutic interventions. Signal Transduct Target Ther. 2023;8(1):168. doi: 10.1038/s41392-023-01430- 7.
  8. Galanth C, Hus-Citharel A, Li B, Llorens-Cortès C. Apelin in the control of body fluid homeostasis and cardiovascular functions. Curr Pharm Des. 2012;18(6):789-98. doi: 10.2174/138161212799277770.
  9. Barnes G, Japp AG, Newby DE. Translational promise of the apelin--APJ system. Heart. 2010;96(13):1011-6. doi: 10.1136/ hrt.2009.191122.
  10. Mughal A, O’Rourke ST. Vascular effects of apelin: mechanisms and therapeutic potential. Pharmacol Ther. 2018;190:139-47. doi: 10.1016/j.pharmthera.2018.05.013.
  11. Uraizee I, Cheng S, Hung CL, Verma A, Thomas JD, Zile MR, et al. Relation of N-terminal pro-B-type natriuretic peptide with diastolic function in hypertensive heart disease. Am J Hypertens. 2013;26(10):1234-41. doi: 10.1093/ajh/hpt098.
  12. Corteville DC, Bibbins-Domingo K, Wu AH, Ali S, Schiller NB, Whooley MA. N-terminal pro-B-type natriuretic peptide as a diagnostic test for ventricular dysfunction in patients with coronary disease: data from the heart and soul study. Arch Intern Med. 2007;167(5):483-9. doi: 10.1001/ archinte.167.5.483.
  13. Shahouzehi B, Shokoohi M, Najafipour H. The effect of opium addiction on serum adiponectin and leptin levels in male subjects: a case control study from Kerman Coronary Artery Disease Risk Factors Study (KERCADRS). EXCLI J. 2013;12:916-23.
  14. Najafipour H, Masoumi M, Amirzadeh R, Rostamzadeh F, Foad R, Shadkam Farrokhi M. Trends in the prevalence and incidence of opium abuse and its association with coronary artery risk factors in adult population in Iran: findings from Kerman Coronary Artery Disease Risk Factors Study. Iran J Med Sci. 2022;47(4):328-37. doi: 10.30476/ ijms.2021.89898.2065.
  15. Farsang C. Role of opioids in the pathophysiology of hypertension. In: Stumpe KO, Kraft K, Faden AI, eds. Opioid Peptides and Blood Pressure Control. Berlin: Springer; 1988. p. 260-74. doi: 10.1007/978-3-642-73429-8.
  16. Masoumi M, Ramezani MA, Karimzadeh H. The relationship of opium addiction with coronary artery disease. Int J Prev Med. 2010;1(3):182-6.
  17. Masoumi M, Shahesmaeili A, Mirzazadeh A, Tavakoli M, Zia Ali A. Opium addiction and severity of coronary artery disease: a case-control study. J Res Med Sci. 2010;15(1):27- 32.
  18. Ziaaddini H, Ziaaddini MR. The household survey of drug abuse in Kerman, Iran. J Appl Sci. 2005;5(2):380-2. doi: 10.3923/jas.2005.380.382.
  19. Najafipour H, Joukar S, Malekpour-Afshar R, Mirzaeipour F, Nasri HR. Passive opium smoking does not have beneficial effect on plasma lipids and cardiovascular indices in hypercholesterolemic rabbits with ischemic and non-ischemic hearts. J Ethnopharmacol. 2010;127(2):257-63. doi: 10.1016/j.jep.2009.11.011.
  20. Headrick JP, Pepe S, Peart JN. Non-analgesic effects of opioids: cardiovascular effects of opioids and their receptor systems. Curr Pharm Des. 2012;18(37):6090-100. doi: 10.2174/138161212803582360.
  21. Rostamzadeh F, Najafipour H, Yeganeh-Hajahmadi M, Esmaeili-Mahani S, Joukar S, Iranpour M. Heterodimerization of apelin and opioid receptors and cardiac inotropic and lusitropic effects of apelin in 2K1C hypertension: role of pERK1/2 and PKC. Life Sci. 2017;191:24-33. doi: 10.1016/j. lfs.2017.09.044.
  22. Zhu P, Huang F, Lin F, Yuan Y, Chen F, Li Q. Plasma apelin levels, blood pressure and cardiovascular risk factors in a coastal Chinese population. Ann Med. 2013;45(7):494-8. doi: 10.3109/07853890.2013.833767.
  23. Sonmez A, Celebi G, Erdem G, Tapan S, Genc H, Tasci I, et al. Plasma apelin and ADMA Levels in patients with essential hypertension. Clin Exp Hypertens. 2010;32(3):179-83. doi: 10.3109/10641960903254505.
  24. Przewlocka-Kosmala M, Kotwica T, Mysiak A, Kosmala W. Reduced circulating apelin in essential hypertension and its association with cardiac dysfunction. J Hypertens. 2011;29(5):971-9. doi: 10.1097/HJH.0b013e328344da76.
  25. Ye L, Ding F, Zhang L, Shen A, Yao H, Deng L, et al. Serum apelin is associated with left ventricular hypertrophy in untreated hypertension patients. J Transl Med. 2015;13:290. doi: 10.1186/s12967-015-0635-5.
  26. Baysal SS, Pirat B, Okyay K, Bal UA, Uluçam MZ, Öztuna D, et al. Treatment-associated change in apelin concentration in patients with hypertension and its relationship with left ventricular diastolic function. Anatol J Cardiol. 2017;17(2):125- 31. doi: 10.14744/AnatolJCardiol.2016.7035.
  27. McKie PM, Cataliotti A, Lahr BD, Martin FL, Redfield MM, Bailey KR, et al. The prognostic value of N-terminal pro-B-type natriuretic peptide for death and cardiovascular events in healthy normal and stage A/B heart failure subjects. J Am Coll Cardiol. 2010;55(19):2140-7. doi: 10.1016/j. jacc.2010.01.031 .
  28. El Maraghi S, Yahia H, Heikal A, Ashraf M. B-type natriuretic peptide in hypertensive crises: diagnostic use in hypertensive urgencies and emergencies. Egypt J Crit Care Med. 2013;1(2):61-7. doi: 10.1016/j.ejccm.2013.01.002.
  29. Phelan D, Watson C, Martos R, Collier P, Patle A, Donnelly S, et al. Modest elevation in BNP in asymptomatic hypertensive patients reflects sub-clinical cardiac remodeling, inflammation and extracellular matrix changes. PLoS One. 2012;7(11):e49259. doi: 10.1371/journal.pone.0049259.
  30. Najafipour H, Beik A. The impact of opium consumption on blood glucose, serum lipids and blood pressure, and related mechanisms. Front Physiol. 2016;7:436. doi: 10.3389/ fphys.2016.00436.
  31. Ziaee M, Hajizadeh R, Khorrami A, Sepehrvand N, Momtaz S, Ghaffari S. Cardiovascular complications of chronic opium consumption: a narrative review article. Iran J Public Health. 2019;48(12):2154-64.
  32. Di Somma S, Sentimentale A, Magrini L, Tega F, Marino R, Ferri E, et al. Elevated B-type natriuretic peptide blood levels during hypertensive crisis. High Blood Press Cardiovasc Prev. 2008;15(1):23-8. doi: 10.2165/00151642-200815010-00005.
  33. Prado G, Alva D, Gonzalez S, Requena T, Campos N, Martinez M, et al. PS 02-72 hypertension and pro-BNP in the emergency room. J Hypertens. 2016;34:e123. doi: 10.1097/01.hjh.0000500199.85844.cb.
  34. Thiele S, Britz S, Landsiedel L, Wallaschofski H, Lohmann T. Short-term changes in hsCRP and NT-proBNP levels in hypertensive emergencies. Horm Metab Res. 2008;40(8):561- 5. doi: 10.1055/s-2008-1073152.
  35. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jr., et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42(6):1206-52. doi: 10.1161/01.HYP.0000107251.49515.c2.
  36. Crim MT, Yoon SS, Ortiz E, Wall HK, Schober S, Gillespie C, et al. National surveillance definitions for hypertension prevalence and control among adults. Circ Cardiovasc Qual Outcomes. 2012;5(3):343-51. doi: 10.1161/ circoutcomes.111.963439.
  37. American Psychiatric Association (APA). Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR. 4th ed. Washington, DC: APA; 2000.
  38. Gupta MD, Girish MP, Shah D, Rain M, Mehta V, Tyagi S, et al. Biochemical and genetic role of apelin in essential hypertension and acute coronary syndrome. Int J Cardiol. 2016;223:374-8. doi: 10.1016/j.ijcard.2016.07.242.
  39. Lu L, Wu D, Li L, Chen L. Apelin/APJ system: a bifunctional target for cardiac hypertrophy. Int J Cardiol. 2017;230:164- 70. doi: 10.1016/j.ijcard.2016.11.215.
  40. DeBosch B, Treskov I, Lupu TS, Weinheimer C, Kovacs A, Courtois M, et al. Akt1 is required for physiological cardiac growth. Circulation. 2006;113(17):2097-104. doi: 10.1161/ circulationaha.105.595231.
  41. Falcão-Pires I, Gonçalves N, Gavina C, Pinho S, Teixeira T, Moura C, et al. Correlation between plasma levels of apelin and myocardial hypertrophy in rats and humans: possible target for treatment? Expert Opin Ther Targets. 2010;14(3):231- 41. doi: 10.1517/14728220903485685.
  42. Ashley EA, Powers J, Chen M, Kundu R, Finsterbach T, Caffarelli A, et al. The endogenous peptide apelin potently improves cardiac contractility and reduces cardiac loading in vivo. Cardiovasc Res. 2005;65(1):73-82. doi: 10.1016/j. cardiores.2004.08.018.
  43. Tavanai A, Asadikaram G, Masoumi M. Opium addiction is associated with increased damage to cardiomyocytes: protective roles played by apelins. Iran Heart J. 2020;21(3):6- 14.
  44. Yeganeh-Hajahmadi M, Najafipour H, Farzaneh F, Esmaeili- Mahani S, Joukar S. Effect of apelin on cardiac contractility in acute reno-vascular hypertension: The role of apelin receptor and kappa opioid receptor heterodimerization. Iran J Basic Med Sci. 2018;21(12):1305-15. doi: 10.22038/ ijbms.2018.31361.7555.
Addiction & Health
Volume 17
Pages 1-8

Files

Share

How to cite

Statistics